Adams
2005
Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Beclomethasone
versus placebo for chronic asthma. Cochrane Database of Systematic
Reviews 2005, Issue 1. Art No: CD002738.
Agresti
1996
Agresti A. An introduction to categorical data analysis. New York
(NY): John Wiley & Sons, 1996.
Altman
1996
Altman DG, Bland JM. Detecting skewness from summary information. BMJ
1996; 313: 1200-1200.
Antman
1992
Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of
results of meta-analyses of randomized control trials and recommendations
of clinical experts: Treatments for myocardial infarction. JAMA
1992; 268: 240-248.
Berlin 1993
Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response
data. Epidemiology 1993; 4: 218-228.
Berlin
1994
Berlin JA, Antman EM. Advantages and limitations of metaanalytic regressions
of clinical trials data. Online Journal of Current Clinical Trials
1994; Doc No 134.
Berlin
2002
Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman KA. Individual patient-
versus group-level data meta-regressions for the investigation of treatment
effect modifiers: ecological bias rears its ugly head. Statistics in
Medicine 2002; 21: 371-387.
Bradburn
2007
Bradburn MJ, Deeks JJ, Berlin JA, Russell LA. Much ado about nothing: a
comparison of the performance of meta-analytical methods with rare events.
Statistics in Medicine 2007; 26: 53-77.
Chinn
2000
Chinn S. A simple method for converting an odds ratio to effect size for
use in meta-analysis. Statistics in Medicine 2000; 19: 3127-3131.
Cooper
1980
Cooper HM, Rosenthal R. Statistical versus traditional procedures for summarizing
research findings. Psychological Bulletin 1980; 87: 442-449.
Crawford
2007
Crawford F, Hollis S. Topical treatments for fungal infections of the skin
and nails of the feet. Cochrane Database of Systematic Reviews
2007, Issue 3. Art No: CD001434.
Deeks
1998
Deeks JJ. Systematic reviews of published evidence: Miracles or minefields?
Annals of Oncology 1998; 9: 703-709.
Deeks 2001
Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity
and combining results from several studies in meta-analysis. In: Egger
M, Davey Smith G, Altman DG (editors). Systematic Reviews in Health
Care: Meta-analysis in Context (2nd edition). London (UK): BMJ Publication
Group, 2001.
Deeks
2002
Deeks JJ. Issues in the selection of a summary statistic for meta-analysis
of clinical trials with binary outcomes. Statistics in Medicine
2002; 21: 1575-1600.
DerSimonian
1986
DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled
Clinical Trials 1986; 7: 177-188.
Egger
1997
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected
by a simple, graphical test. BMJ 1997; 315: 629-634.
Engels
2000
Engels EA, Schmid CH, Terrin N, Olkin I, Lau J. Heterogeneity and statistical
significance in meta-analysis: an empirical study of 125 meta-analyses.
Statistics in Medicine 2000; 19: 1707-1728.
Greenland 1985
Greenland S, Robins JM. Estimation of a common effect parameter from sparse
follow-up data. Biometrics 1985; 41: 55-68.
Greenland
1987
Greenland S. Quantitative methods in the review of epidemiologic literature.
Epidemiologic Reviews 1987; 9: 1-30.
Greenland
1992
Greenland S, Longnecker MP. Methods for trend estimation from summarized
dose-response data, with applications to meta-analysis. American Journal
of Epidemiology 1992; 135: 1301-1309.
Hasselblad
1995
Hasselblad VIC, Mccrory DC. Meta-analytic tools for medical decision making:
A practical guide. Medical Decision Making 1995; 15: 81-96.
Higgins
2002
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis.
Statistics in Medicine 2002; 21: 1539-1558.
Higgins
2003
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency
in meta-analyses. BMJ 2003; 327: 557-560.
Higgins
2004
Higgins JPT, Thompson SG. Controlling the risk of spurious findings from
meta-regression. Statistics in Medicine
2004; 23: 1663-1682.
Higgins
2008
Higgins JPT, White IR, Anzures-Cabrera J. Meta-analysis of skewed data:
combining results reported on log-transformed or raw scales. Statistics
in Medicine (in press, 2008).
Kjaergard
2001
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies
between large and small randomized trials in meta-analyses. Annals
of Internal Medicine 2001; 135: 982-989.
Laupacis
1988
Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful
measures of the consequences of treatment. New England Journal of Medicine
1988; 318: 1728-1733.
Mantel
1959
Mantel N, Haenszel W. Statistical aspects of the analysis of data from
retrospective studies of disease. Journal of the National Cancer Institute
1959; 22: 719-748.
McIntosh
1996
McIntosh MW. The population risk as an explanatory variable in research
synthesis of clinical trials. Statistics in Medicine 1996; 15:
1713-1728.
Moher
2005
Moher M, Hey K, Lancaster T. Workplace interventions for smoking cessation.
Cochrane Database of Systematic Reviews 2005, Issue 2. Art No:
CD003440.
Morgenstern
1982
Morgenstern H. Uses of ecologic analysis in epidemiologic research. American
Journal of Public Health 1982; 72: 1336-1344.
O'Rourke
1989
O'Rourke K, Detsky AS. Meta-analysis in medical research: strong encouragement
for higher quality in individual research efforts. Journal of Clinical
Epidemiology 1989; 42: 1021-1026.
Oxman
1992
Oxman AD, Guyatt GH. A consumers guide to subgroup analyses. Annals
of Internal Medicine 1992; 116: 78-84.
Pittler
2003
Pittler MH, Ernst E. Kava extract versus placebo for treating anxiety.
Cochrane Database of Systematic Reviews 2003, Issue 1. Art No:
CD003383.
Poole
1999
Poole C, Greenland S. Random-effects meta-analyses are not always conservative.
American Journal of Epidemiology 1999; 150: 469-475.
Sackett
1996
Sackett DL, Deeks JJ, Altman DG. Down with odds ratios! Evidence Based
Medicine 1996; 1: 164-166.
Sackett
1997
Sackett DL, Richardson WS, Rosenberg W, Haynes BR. Evidence-based medicine:
how to practice and teach EBM. Edinburgh (UK): Churchill Livingstone,
1997.
Sharp
2000
Sharp SJ. Analysing the relationship between treatment benefit and underlying
risk: precautions and practical recommendations. In: Egger M, Davey Smith
G, Altman DG (editors). Systematic Reviews in Health Care: Meta-analysis
in Context (2nd edition). London (UK): BMJ Publication Group, 2000.
Sinclair
1994
Sinclair JC, Bracken MB. Clinically useful measures of effect in binary
analyses of randomized trials. Journal of Clinical Epidemiology
1994; 47: 881-889.
Thompson 1997
Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source
of heterogeneity in meta-analysis. Statistics in Medicine 1997;
16: 2741-2758.
Thompson
1999
Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison
of methods. Statistics in Medicine 1999; 18: 2693-2708.
Thompson
2002
Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken
and interpreted? Statistics in Medicine 2002; 21: 1559-1574.
Whitehead
1991
Whitehead A, Whitehead J. A general parametric approach to the meta-analysis
of randomised clinical trials. Statistics in Medicine 1991; 10:
1665-1677.
Whitehead
1994
Whitehead A, Jones NMB. A meta-analysis of clinical trials involving different
classifications of response into ordered categories. Statistics in
Medicine 1994; 13: 2503-2515.
Yusuf
1985
Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and
after myocardial infarction: an overview of the randomised trials. Progress
in Cardiovascular Diseases 1985; 27: 335-371.
Yusuf
1991
Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation
of treatment effects in subgroups of patients in randomized clinical trials.
JAMA 1991; 266: 93-98.